Projects funded by the NCN
Liposomal berberine and anti-CD47 antibody as an effective therapy for the treatment of colorectal cancer
2019/33/N/NZ5/02758
Keywords:
colon cancer berberine liposomes CD47 receptor phagocytosis antiCD47 antibody
Descriptors:
- NZ5_7: Human disease treatment
- NZ6_1: Adaptive and innate immunity
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Wrocławski, Wydział Biotechnologii
woj.
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 17 - announced on 2019-03-15
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2020-02-05
Project end date (Y-m-d): 2024-02-04
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Dual Role of Vitamin C-Encapsulated Liposomal Berberine in Effective Colon Anticancer ImmunotherapyAuthors:Martyna Mianowska, Magdalena Zaremba-Czogalla, Adrianna Zygmunt, Mohamed Mahmud, Regine Süss, Jerzy GubernatorAcademic press:Pharmaceuticals (rok: 2023, tom: 17(1):5, strony: 45687), Wydawca: MDPIStatus:PublishedDOI:10.3390/ph17010005 - link to the publication